KIMBERLY RECKTENWALD: Open Payments
NPI 1346603891 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 49 payments from 16 companies in 2025. Trend: 2023 $400 · 2024 $615 · 2025 $1,148
Food & beverage: $1,087Education: $61
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 8 | $331 |
| UCB, Inc. | 9 | $187 |
| Janssen Biotech, Inc. | 5 | $131 |
| ARGENX US, INC. | 4 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| SpringWorks Therapeutics, Inc. | 2 | $50 |
| ABBVIE INC. | 3 | $48 |
| Eisai Inc. | 3 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
Products named: ULTOMIRIS, Rystiggo, HYQVIA, Nayzilam, GOMEKLI, Leqembi, AUSTEDO XR, VYVGART.
Industry payments across KY — which companies pay providers there.
